Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages 406-416

  Moore, Jason ^a,c   Tomson, Charles R V ^b   Tessa Savage, M ^b   Borrows, Richard ^a   Ferro, Charles J ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Allograft survival; Calcium; Kidney transplantation; Mortality; Phosphate

Indexed keywords

ALBUMIN; CALCIUM; CHOLESTEROL; CREATININE; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; SURVIVAL;

ADULT; CALCIUM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHATES; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 79958711339     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01292.x     Document Type: Article

References (42)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004: 351: 1296.
2. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
3. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998: 11: 239.
4. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000: 11: 1735.
5. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005: 112: 2627.
6. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007: 167: 879.
7. Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008: 52: 661.
8. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998: 31: 607.
9. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 2009: 87: 1040.
10. Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007: 21: 558.
11. Schaeffner ES, Fodinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int 2007: 20: 247.
12. Roodnat JI, Van Gurp EA, Mulder PG et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation 2006: 82: 362.
13. Raggi P, Giachelli C, Bellasi A. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med 2007: 4: 26.
14. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006: 27: 2588.
15. Wilkinson IB, MacCallum H, Hupperetz PC, Van Thoor CJ, Cockcroft JR, Webb DJ. Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol 2001: 530: 541.
16. Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002: 62: 166.
17. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006: 145: 247.
18. Neter JWW, Kutner M. Applied Linear Statistical Models, 2nd edn. Irwin, New York, 1985: 166.
19. Mead RCR, Hasted A. Statistical Methods in Agriculture and Experimental Biology, 2nd edn. Chapman and Hall, 1993: 17 and 167.
20. Draper NSH. Applied Regression Analysis, 2nd edn. Wiley-Interscience, New York, 1981: 307.
21. Montgomery DPE, Vinning G. Introduction to Linear Regression Analysis, 4th edn. Wiley-Interscience, New York, 2006: 279.
22. Grey A, Mitnick MA, Masiukiewicz U et al. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 1999: 140: 4683.
23. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003: 41: 105.
24. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008: 359: 584.
25. Orsenigo E, Socci C, Carlucci M et al. Multivariate analysis of factors affecting patient and graft survival after renal transplant. Transplant Proc 2005: 37: 2461.
26. Moore J, He X, Cockwell P, Little MA, Johnston A, Borrows R. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Transplantation 2008: 86: 564.
27. Gourishankar S, Hunsicker LG, Jhangri GS, Cockfield SM, Halloran PF. The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephrol 2003: 14: 2387.
28. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002: 62: 311.
29. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002: 73: 70.
30. Ruilope LM. Angiotensin receptor blockers: RAAS blockade and renoprotection. Curr Med Res Opin 2008: 24: 1285.
31. Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006: 17: 889.
32. Opelz G, Zeier M, Laux G, Morath C, Dohler B. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 2006: 17: 3257.
33. Levi R, Silver J. Vitamin D supplementation after renal transplantation: how much vitamin D should we prescribe? Kidney Int 2009: 75: 576.
34. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.8. Bone disease. Nephrol Dial Transplant 2002: 17(Suppl. 4): 43.
35. Courbebaisse M, Thervet E, Souberbielle JC et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2009: 75: 646.
36. Evenepoel P, Meijers BK, De Jonge H et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 2008: 3: 1829.
37. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005: 16: 520.
38. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005: 46: 1753.
39. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001: 103: 987.
40. Williams B, Lacy PS, Thom SM et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006: 113: 1213.
41. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004: 4: 1662.
42. Matas AJ, Gillingham KJ, Humar A et al. 2202 kidney transplant recipients with 10years of graft function: what happens next? Am J Transplant 2008: 8: 2410.